Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE)-Reference-Cited by-同舟云学术

Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE)

Published:2023-01 Issue:10370 Volume:401 Page:38-48
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Merola Joseph F,Landewé Robert,McInnes Iain B,Mease Philip J,Ritchlin Christopher T,Tanaka Yoshiya,Asahina Akihiko,Behrens Frank,Gladman Dafna D,Gossec Laure,Gottlieb Alice B,Thaçi Diamant,Warren Richard B,Ink Barbara,Assudani Deepak,Bajracharya Rajan,Shende Vishvesh,Coarse Jason,Coates Laura C

Funder

Manchester Biomedical Research Centre

UCB Pharma

Publisher

Elsevier BV

Subject

General Medicine

Reference31 articles.

1. The pathogenesis of psoriatic arthritis;Veale;Lancet,2018

2. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021;Coates;Nat Rev Rheumatol,2022

3. The contribution of joint and skin improvements to the health-related quality of life of patients with psoriatic arthritis: a post hoc analysis of two randomised controlled studies;Kavanaugh;Ann Rheum Dis,2019

4. Residual disease associated with suboptimal treatment response in patients with psoriatic arthritis: a systematic review of real-world evidence;Coates;Rheumatol Ther,2022

5. Treatment patterns, unmet need, and impact on patient-reported outcomes of psoriatic arthritis in the United States and Europe;Gottlieb;Rheumatol Int,2019

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in psoriasis research: From pathogenesis to therapeutics;Life Sciences;2024-10

2. Targeted therapies for uveitis in spondyloarthritis: A narrative review;Joint Bone Spine;2024-09

3. Innovations in Psoriasis;Dermatologic Clinics;2024-09

4. Treatment strategies for Spondyloarthritis: Implementation of precision medicine – Or “one size fits all” concept?;Autoimmunity Reviews;2024-09

5. Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies;Rheumatology and Therapy;2024-08-31